Venturi Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-545
Closed -$125K 1553
2024
Q4
$125K Buy
545
+204
+60% +$49.1K 0.01% 686
2024
Q3
$83.2K Buy
341
+122
+56% +$27.3K ﹤0.01% 616
2024
Q2
$41.9K Buy
219
+103
+89% +$20.9K ﹤0.01% 721
2024
Q1
$23K Buy
116
+25
+27% +$4.58K ﹤0.01% 698
2023
Q4
$15.7K Buy
91
+23
+34% +$3.53K ﹤0.01% 769
2023
Q3
$10.1K Sell
68
-5,105
-99% -$923K ﹤0.01% 807
2023
Q2
$1.13M Buy
5,173
+185
+4% +$41.2K 0.09% 131
2023
Q1
$1.09M Sell
4,988
-342
-6% -$74.2K 0.09% 143
2022
Q4
$1.11M Buy
5,330
+498
+10% +$109K 0.1% 148
2022
Q3
$1.05M Sell
4,832
-53
-1% -$12.1K 0.1% 127
2022
Q2
$1.02M Buy
4,885
+12
+0.2% +$2.56K 0.09% 134
2022
Q1
$1.18M Buy
4,873
+327
+7% +$79.1K 0.09% 128
2021
Q4
$1.18M Sell
4,546
-124
-3% -$32.2K 0.09% 145
2021
Q3
$1.23M Sell
4,670
-1,255
-21% -$343K 0.1% 128
2021
Q2
$1.46M Buy
5,925
+290
+5% +$61K 0.13% 109
2021
Q1
$1.09M Buy
5,635
+52
+0.9% +$10.4K 0.1% 139
2020
Q4
$1.19M Buy
5,583
+587
+12% +$117K 0.12% 123
2020
Q3
$856K Buy
+4,996
New +$923K 0.1% 145

Other funds holding RMD

Venturi Wealth Management's RMD Position: Q1 2025 in Review

Venturi Wealth Management sold out of ResMed (RMD) in Q1 2025, closing a stake of 545 shares — an estimated $125K sold.

Venturi Wealth Management first reported a position in RMD in Q3 2020 and held it in 18 quarters. The position peaked at $1.46M in Q2 2021. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Venturi Wealth Management reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 545 ResMed shares in Q1 2025, an estimated $125K.
  • Venturi Wealth Management first reported a position in ResMed in Q3 2020 and held it in 18 quarters.
  • Venturi Wealth Management's ResMed position peaked at $1.46M in Q2 2021.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.